District of Columbia
Regeneron Pharmaceuticals, Inc. has filed an application under docket 26-cv-00416. The recent docket activity notes pro hac vice fee payments for two attorneys, indicating out-of-state counsel involvement. The nature of the application or underlying dispute is not specified in the summary provided.